Dan Gebremedhin M.D.

Dan Gebremedhin MD, MBA is a partner at Flare Capital Partners since April 2015, focusing on early-stage healthcare technology investments. Dan serves as a board member for several healthcare organizations, including Vita Health, Positive Development, Somatus, Oui Therapeutics, and Eden Health, where Dan contributes to innovative patient care models and technological advancements. Additionally, Dan holds board observer roles at Elektra Health and Aetion, emphasizing real-world evidence and women's health issues. Dan graduated with an MBA from Harvard Business School, an MD from Morehouse School of Medicine, and a BS in Biology from UC San Diego.